OMEICOS Therapeutics Completes Enrollment of PMD-OPTION Study in Primary Mitochondrial Disease
26 sept. 2024 06h00 HE
|
OMEICOS Therapeutics GmbH
Interim data confirms OMT-28’s strong safety profile in PMD patients, top-line data expected mid-2025 BERLIN, GERMANY, September 26, 2024 – OMEICOS, a biopharmaceutical company developing...
pMD®️ Launches New Website Reflecting Shift to End-to-End Healthcare Solutions
01 sept. 2022 15h00 HE
|
pMD
SAN FRANCISCO, Sept. 01, 2022 (GLOBE NEWSWIRE) -- pMD®, a company that provides end-to-end solutions for health care providers and patients, announced they have launched a new public website that...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Psychemedics Corporation – PMD
27 févr. 2017 18h05 HE
|
The Rosen Law Firm PA
NEW YORK, Feb. 27, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Psychemedics Corporation...
SocialCode and Moontoast Partner to Deliver Deeper Facebook Ad Engagement and ROI
25 mars 2013 09h00 HE
|
Moontoast
NASHVILLE, TN and BOSTON, MA--(Marketwire - Mar 25, 2013) - Moontoast, an innovative Social Rich Media advertising platform leader, today announced a partnership with SocialCode, the leading social...
Moontoast Wins Facebook Preferred Marketing Developer Innovation Competition
19 mars 2013 14h31 HE
|
Moontoast
NASHVILLE, TN and BOSTON, MA--(Marketwire - Mar 19, 2013) - Moontoast, a Facebook Preferred Marketing Developer (PMD), announced today that it has been named a winner in the Facebook PMD Innovation...
BNOTIONS Named Facebook Preferred Marketing Developer
19 avr. 2012 09h59 HE
|
BNOTIONS
TORONTO, April 19, 2012 (GLOBE NEWSWIRE) -- BNOTIONS, a leading technology company specializing in Facebook, mobile and web application development, announced today it has been named a...
StemCells, Inc. Announces First Human Neural Stem Cell Transplant in Landmark Myelination Disorder Trial
10 févr. 2010 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., Feb. 10, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that its proprietary HuCNS-SC® human neural stem cells have been used to treat the first patient...